| Complex immune dysregulation in COVID-19 patients with severe respiratory failure EJ Giamarellos-Bourboulis, MG Netea, N Rovina, K Akinosoglou, ... Cell host & microbe 27 (6), 992-1000. e3, 2020 | 2116 | 2020 |
| Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007 ECMMWGZ A Skiada 1, L Pagano, A Groll, S Zimmerli, B Dupont, K Lagrou, C ... Clin Microbiol Infect 17 (12), 1859-1867, 2011 | 798 | 2011 |
| Antimicrobial drug use and resistance in Europe FM van de Sande-Bruinsma N, Grundmann H, Verloo D, Tiemersma E, Monen J ... Emerg Infect Dis 14, 1722-1730, 2008 | 636 | 2008 |
| Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram … D Plachouras, M Karvanen, LE Friberg, E Papadomichelakis, ... Antimicrobial agents and chemotherapy 53 (8), 3430-3436, 2009 | 623 | 2009 |
| Major Clinical Outcomes in Antiretroviral Therapy (ART)-naive Participants and in Those Not Receiving ART at Baseline in the SMART Study RW Strategies for Management of Antiretroviral Therapy (SMART) Study Group ... J Infect Dis 197 (8), 1133-1144, 2008 | 576 | 2008 |
| European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in Europe (1997–2009) N Adriaenssens, S Coenen, A Versporten, A Muller, G Minalu, C Faes, ... Journal of antimicrobial chemotherapy 66 (suppl_6), vi47-vi56, 2011 | 532 | 2011 |
| Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial M Paul, GL Daikos, E Durante-Mangoni, D Yahav, Y Carmeli, YD Benattar, ... The lancet Infectious diseases 18 (4), 391-400, 2018 | 515 | 2018 |
| Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective … B Gutiérrez-Gutiérrez, E Salamanca, M de Cueto, PR Hsueh, P Viale, ... The Lancet Infectious Diseases 17 (7), 726-734, 2017 | 479 | 2017 |
| An Outbreak of Infection due to β-Lactamase Klebsiella pneumoniae Carbapenemase 2–Producing K. pneumoniae in a Greek University Hospital: Molecular … M Souli, I Galani, A Antoniadou, E Papadomichelakis, G Poulakou, ... Clinical infectious diseases 50 (3), 364-373, 2010 | 437 | 2010 |
| Acinetobacter baumannii: a universal threat to public health? H Giamarellou, A Antoniadou, K Kanellakopoulou International journal of antimicrobial agents 32 (2), 106-119, 2008 | 421 | 2008 |
| Colistin-resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients: first report of a multiclonal cluster A Antoniadou, F Kontopidou, G Poulakou, E Koratzanis, I Galani, ... Journal of Antimicrobial Chemotherapy 59 (4), 786-790, 2007 | 323 | 2007 |
| Application of a loading dose of colistin methanesulfonate in critically ill patients: population pharmacokinetics, protein binding, and prediction of bacterial kill AF Mohamed, I Karaiskos, D Plachouras, M Karvanen, K Pontikis, ... Antimicrobial agents and chemotherapy 56 (8), 4241-4249, 2012 | 309 | 2012 |
| Inferior Clinical Outcome of the CD4+ Cell Count-Guided Antiretroviral Treatment Interruption Strategy in the SMART Study: Role of CD4+ Cell Counts and HIV RNA Levels During … ANP Strategies for Management of Antiretroviral Therapy (SMART) Study Group ... J Infect Dis 197 (8), 1145-1155, 2008 | 259 | 2008 |
| A Research Agenda on the Management of Intra-Abdominal Candidiasis: Results From a Consensus of Multinational Experts Intensive Care Med 39 (12), 2092-2106, 2013 | 222 | 2013 |
| Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation AD Nordell, M McKenna, ÁH Borges, D Duprez, J Neuhaus, JD Neaton, ... Journal of the American Heart Association 3 (3), e000844, 2014 | 221 | 2014 |
| Identification of targets for quality improvement in antimicrobial prescribing: the web-based ESAC Point Prevalence Survey 2009 P Zarb, B Amadeo, A Muller, N Drapier, V Vankerckhoven, P Davey, ... Journal of Antimicrobial Chemotherapy 66 (2), 443-449, 2011 | 205 | 2011 |
| CD4 cell count and the risk of AIDS or death in HIV-Infected adults on combination antiretroviral therapy with a suppressed viral load: a longitudinal cohort study from COHERE PLoS medicine 9 (3), 2012 | 200 | 2012 |
| Transmission of HIV drug resistance and the predicted effect on current first-line regimens in Europe LM Hofstra, N Sauvageot, J Albert, I Alexiev, F Garcia, D Struck, ... Clinical infectious diseases 62 (5), 655-663, 2016 | 189 | 2016 |
| Activation and Coagulation Biomarkers Are Independent Predictors of the Development of Opportunistic Disease in Patients With HIV Infection ISMATSSG Alison J Rodger 1, Zoe Fox, Jens D Lundgren, Lewis H Kuller ... J Infect Dis 200 (6), 973-983, 2009 | 185 | 2009 |
| Sequence Analysis of in Vivo Defective Interfering-Like RNA of Influenza A H1N1 Pandemic Virus GE Saira K, Lin X, DePasse JV, Halpin R, Twaddle A, Stockwell T, Angus B ... J Virol 87 (14), 8064-8074, 2013 | 172 | 2013 |
